Animal models impacted by phytoestrogens in commercial chow: Implications for pathways influenced by hormones

Laboratory Investigation

Volumn 81, Issue 5, 2001, Pages 735-747

  Brown, Nadine M ^a   Setchell, Kenneth D R ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOFLAVONE; PHYTOESTROGEN;

ANIMAL EXPERIMENT; ARTICLE; BIOAVAILABILITY; BREAST MILK; DIET; FEMALE; GENOTYPE; MOUSE; NONHUMAN; PHENOTYPE; PLACENTAL TRANSFER; PRIORITY JOURNAL; RAT; SOYBEAN;

EID: 0035023734     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3780282     Document Type: Article

References (97)

1. Adlercreutz H (1962). Studies on oestrogen excretion in human bile. Acta Endocrinol Suppl (Copenh) 72:1-220.
2. Adlercreutz H, Bannwart C, Wahala K, Makela T, Brunow G, Hase T, Arosemena PJ, Kellis JT, and Vickery LE (1993a). Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens. J Steroid Biochem Mol Biol 44:147-153.
3. Adlercreutz H, Fotsis T, Lampe J, Wahala K, Makela T, Brunow G, and Hase T (1993b). Quantitative determination of lignans and isoflavonoids in serum of omnivorous and vegetarian women by isotope dilution gas chromatographymass spectrometry. Scand J Clin Lab Invest Suppl 215:5-18.
4. Adlercreutz H, Honjo H, Higashi A, Fotsis T, Hamalainen E, Hasegawa T, and Okada H (1991). Urinary excretion of lignans and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional Japanese diet. Am J Clin Nutr 54:1093-1100.
5. Adlercreutz H and Martin F (1980). Biliary excretion and intestinal metabolism of progesterone and estrogens in man. J Steroid Biochem 13:231-244.
6. Adlercreutz H, Mousavi Y, Clark J, Hockerstedt K, Hamalainen E, Wahala K, Makela T, and Hase T (1992). Dietary phytoestrogens and cancer: In vitro and in vivo studies. J Steroid Biochem Mol Biol 41:331-337.
7. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M, and Fukami Y (1987). Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 262:5592-5595.
8. Anderson JJ, Ambrose WW, and Garner SC (1998). Biphasic effects of genistein on bone tissue in the ovariectomized, lactating rat model. Proc Soc Exp Biol Med 217:345-350.
9. Anderson JW, Johnstone BM, and Cook-Newell ME (1995). Meta-analysis of the effects of soy protein intake on serum lipids (see comments). N Engl J Med 333:276-282.
10. Arjmandi BH, Birnbaum R, Goyal NV, Getlinger MJ, Juma S, Alekel L, Hasler CM, Drum ML, Hollis BW, and Kukreja SC (1998). Bone-sparing effect of soy protein in ovarian hormone-deficient rats is related to its isoflavone content. Am J Clin Nutr 68:1364S-1368S.
11. Ashby J, Tinwell H, Soames A, and Foster J (1999). Induction of hyperplasia and increased DNA content in the uterus of immature rats exposed to coumestrol. Environ Health Perspect 107:819-822.
12. Axelson M, Kirk DN, Farrant RD, Cooley G, Lawson AM, and Setchell KDR (1982). The identification of the weak oestrogen equol (7-hydroxy-3-[4′-hydroxyphenyl]chroman) in human urine. Biochem J 201:353-357.
13. Axelson M and Setchell KDR (1980). Conjugation of lignans in human urine. FEBS Lett 122:49-53.
14. Axelson M and Setchell KDR (1981). The excretion of lignans in rats: Evidence for an intestinal bacterial source for this new group of compounds. FEBS Lett 123:337-342.
15. Axelson M, Sjovall J, Gustafsson BE, and Setchell KDR (1984). Soya: A dietary source of the non-steroidal oestrogen equol in man and animals. J Endocrinol 102:49-56.
16. Baraldi P, Spalluto G, Cacciari B, Romangnoli R, and Setchell KDR (1999). Chemical synthesis of [13C]Daidzein. J Med Food 2:99-102.
17. Barkley MS, Lasley BL, Thompson MA, and Shackleton CHL (1985). Equol: A contributor to enigmatic immunoassay measurements of estrogen. Steroids 46:587-608.
18. Barnes S, Grubbs C, Setchell KDR, and Carlson J (1990). Soybeans inhibit mammary tumors in models of breast cancer. Prog Clin Biol Res 347:239-253.
19. Barnes S, Peterson G, Grubbs C, and Setchell KDR (1994). Potential role of dietary isoflavones in the prevention of cancer. Adv Exp Med Biol 354:135-147.
20. Barnes S and Peterson TG (1995). Biochemical targets of the isoflavone genistein in tumor cell lines. Proc Soc Exp Biol Med 208:103-108.
21. Bennetts HW, Underwood EJ, and Shier FL (1946). A specific breeding problem of sheep on subterranean clover pastures in Western Australia. Aust J Agric Res 22:131-138.
22. Bennick M, Thiagarajan D, Bourquin L, and Mayle J (1999). Dietary soy is associated with decreased cell proliferation rate and zone in colon mucosa of subjects at risk for colon cancer. Proceedings of the Third International Symposium on the Role of Soy in Preventing and Treating Chronic Disease. J Nutr 130 (Suppl).
23. Bickoff EM, Livingston AL, Hendrickson AP, and Booth AN (1962). Relative potencies of several estrogen-like compounds found in forages. Agric Food Chem 10:410-412.
24. Blair HC, Jordan SE, Peterson TG, and Barnes S (1996). Variable effects of tyrosine kinase inhibitors on avian osteoclastic activity and reduction of bone loss in ovariectomized rats. J Cell Biochem 61:629-637.
25. Boettger-Tong H, Murthy L, Chiappetta C, Kirkland JL, Goodwin B, Adlercreutz H, Stancel GM, and Makela S (1998). A case of a laboratory animal feed with high estrogenic activity and its impact on in vivo responses to exogenously administered estrogens. Environ Health Perspect 106:369-373.
26. Borriello SP, Setchell KD, Axelson M, and Lawson AM (1985). Production and metabolism of lignans by the human faecal flora. J Appl Bacteriol 58:37-43.
27. Brown NM, Wang J, Cotroneo MS, Zhao YX, and Lamartiniere CA (1998). Prepubertal genistein treatment modulates TGF-alpha, EGF and EGF-receptor mRNAs and proteins in the rat mammary gland. Mol Cell Endocrinol 144:149-165.
28. Brzozowski AM, Pike AC, Dauter Z, Hubbard RE, Bonn T, Engstrom O, Ohman L, Greene GL, Gustafsson JA, and Carlquist M (1997). Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389:753-758.
29. Butcher RL, Collins WE, and Fugo NW (1974). Serum concentration of LH, FSH, prolactin, progesterone and estradiol-17beta throughout the 4-day estrous cycle of the rat. Endocrinology 94:1704-1708.
30. Cassidy A, Bingham S, and Setchell KDR (1994). Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women (see comments). Am J Clin Nutr 60:333-340.
31. Constantinou Al, Mehta RG, and Vaughan A (1996). Inhibition of N-methyl-N-nitrosourea-induced mammary tumors in rats by the soybean isoflavones. Anticancer Res 16:3293-3298.
32. Coward L, Barnes NC, Setchell KDR, and Barnes S (1993). Genistein and daidzein, and their β-glycosides conjugates: Anti-tumor isoflavones in soybean foods from American and Asian diets. J Agric Food Chem 41:1961-1967.
33. Crouse JR 3rd, Morgan T, Terry JG, Ellis J, Vitolins M, and Burke GL (1999). A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins. Arch Intern Med 159:2070-2076.
34. Dalu A, Haskell JF, Coward L, and Lamartiniere CA (1998). Genistein, a component of soy, inhibits the expression of the EGF and ErbB2/Neu receptors in the rat dorsolateral prostate. Prostate 37:36-43.
35. Day AJ, DuPont MS, Ridley S, Rhodes M, Rhodes MJ, Morgan MR, and Williamson G (1998). Deglycosylation of flavonoid and isoflavonoid glycosides by human small intestine and liver beta-glucosidase activity. FEBS Lett 436:71-75.
36. Drane H, Patterson D, Roberts B, and Saba N (1975). The chance discovery of oestrogenic activity in laboratory rat cake. Food Cosmetics Toxicol 13:491-492.
37. Eldridge A (1982). Determination of isoflavones in soybean flours, protein concentrates and isolates. J Agric Food Chem 30:353-355.
38. Eldridge A and Kwolek W (1983). Soybean isoflavones: Effects of environment and variety on composition. J Agric Food Chem 31:394-396.
39. Evans BA, Griffiths K, and Morton MS (1995). Inhibition of 5 alpha-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids. J Endocrinol 147: 295-302.
40. Food and Drug Administration (1999). FDA Talk Paper: FDA approves new health claim for soy protein and coronary heart disease. Available at http://www.fda.gov/bbs/topics/ ANSWERS/ANS00980.html. Accessed March 26, 2001.
41. Franke A, Custer L, Cerna C, and Marala K (1995). Rapid HPLC analysis of dietary phytoestrogens from legumes and from human urine. Proc Soc Exp Biol Med 208:18-26.
42. Fritz WA, Coward L, Wang J, and Lamartiniere CA (1998). Dietary genistein: Perinatal mammary cancer prevention, bioavailability and toxicity testing in the rat. Carcinogenesis 19:2151-2158.
43. Harrison E, Adjei A, Ameho C, Yamamoto S, and Kono S (1998). The effect of soybean protein on bone loss in a rat model of postmenopausal osteoporosis. J Nutr Sci Vitaminol (Tokyo) 44:257-268.
44. Helferich W, Hsieh CY, and Santell R (1998). Paradoxical effects of the phytoestrogen genistein on growth of estrogen-dependent human breast cancer cells in vitro and in vivo. In: Dunaif GE, Olin SS, Scimeca J, and Thomas JA, editors.
45. Human diet and endocrine modulation: Estrogenic and androgenic effects. Washington, DC: ILSI Press, 166-179.
46. Ishida H, Uesugi T, Hirai K, Toda T, Nukaya H, Yokotsuka K, and Tsuji K (1998). Preventive effects of the plant isoflavones, daidzin and genistin, on bone loss in ovariectomized rats fed a calcium-deficient diet. Biol Pharm Bull 21:62-66.
47. Jenkins DJA, Kendall CWC, Garsetti M, Rosenberg-Zand RS, Jackson C-J, Agarwal S, Rao AV, Diamandis EP, Parker T, Faulkner D, Vuksan V, and Vidgen E (2000). Effect of soy protein foods on low-density lipoprotein oxidation and ex vivo sex hormone receptor activity: A controlled crossover trial. Metabolism 49:537-543.
48. Kapiotis S, Hermann M, Held I, Seelos C, Ehringer H, and Gmeiner BM (1997). Genistein, the dietary-derived angiogenesis inhibitor, prevents LDL oxidation and protects endothelial cells from damage by atherogenic LDL. Arterioscler Thromb Vasc Biol 17:2868-2874.
49. Kim H, Peterson TG, and Barnes S (1998). Mechanisms of action of the soy isoflavone genistein: Emerging role for its effects via transforming growth factor beta signaling pathways. Am J Clin Nutr 68:1418S-1425S.
50. Kirk EA, Sutherland P, Wang SA, Chait A, and LeBoeuf RC (1998). Dietary isoflavones reduce serum cholesterol and atherosclerosis in C57BL/6 mice but not LDL receptor-deficient mice. J Nutr 128:954-959.
51. Knuckles BE, deFremery D, and Kohler GO (1976). Coumestrol content of fractions obtained during wet processing of alfalfa. J Agric Food Chem 24:1177-1180.
52. Kuiper GG, Lemmen JG, Carlsson B, Cotton JC, Safe SH, van der Saag PT, van der Burg B, and Gustafsson JA (1998a). Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139:4252-4263.
53. Kuiper GGJM, Nilsson S, and Gustaffson J-A (1998b). Characteristics and function of the novel estrogen receptor-β. In: Hormones and signaling, vol 1. New York: Academic Press, 89-112.
54. Lamartiniere C and Holland M (1992). Neonatal diethylstilbesterol prevents spontaneously developing mammary tumors. In: Li J, Nandi S, Li S, editors. Proceedings of the First International Symposium on Hormonal Carcinogenesis. New York: Springer Verlag, 305-308.
55. Lamartiniere CA, Moore J, Holland M, and Barnes S (1995a). Neonatal genistein chemoprevents mammary cancer. Proc Soc Exp Biol Med 208:120-123.
56. Lamartiniere CA, Moore JB, Brown NM, Thompson R, Hardin MJ, and Barnes S (1995b). Genistein suppresses mammary cancer in rats. Carcinogenesis 16:2833-2840.
57. Lamartiniere CA, Murrill WB, Manzolillo PA, Zhang JX, Barnes S, Zhang X, Wei H, and Brown NM (1998a). Genistein alters'the ontogeny of mammary gland development and protects against chemically-induced mammary cancer in rats. Proc Soc Exp Biol Med 217:358-364.
58. Lamartiniere CA, Zhang JX, and Cotroneo MS (1998b). Genistein studies in rats: Potential for breast cancer prevention and reproductive and developmental toxicity. Am J Clin Nutr 68:1400S-1405S.
59. Madani S, Lopez S, Blond JP, Prost J, and Belleville J (1998). Highly purified soybean protein is not hypocholesterolemic in rats but stimulates cholesterol synthesis and excretion and reduces polyunsaturated fatty acid biosynthesis. J Nutr 128: 1084-1091.
60. Makela S, Poutanen M, Lehtimaki J, Kostian ML, Santti R, and Vihko R (1995a). Estrogen-specific 17 beta-hydroxysteroid oxidoreductase type 1 (E.C. 1.1.1.62) as a possible target for the action of phytoestrogens. Proc Soc Exp Biol Med 208:51-59.
61. Makela S, Santti R, Salo L, and McLachlan JA (1995b). Phytoestrogens are partial estrogen agonists in the adult male mouse. Environ Health Perspect (103 Suppl) 7:123-127.
62. Makela SI, Pylkkanen LH, Santti RS, and Adlercreutz H (1995c). Dietary soybean may be antiestrogenic in male mice. J Nutr 125:437-445.
63. Mathieson R and Kitts WD (1980). Binding of phytoestrogen and estradiol 17β by cytoplasmic receptors in the pituitary gland and hypothalamus of the ewe. J Endocrinol 85:317-325.
64. Morton MS, Wilcox G, Wahlqvist ML, and Griffiths K (1994). Determination of lignans and isoflavonoids in human female serum following dietary supplementation. J Endocrinol 142: 251-259.
65. Murphy PA (1982). Phytoestrogen content of processed soybean products. Food Technol 43:60-64.
66. Murphy PA, Farmakelidis E, and Johnson L (1982). Isoflavone content of soya-based laboratory animal diets. Food Chem Toxicol 20:315-317.
67. Murrill WB, Brown NM, Zhang JX, Manzolillo PA, Barnes S, and Lamartiniere CA (1996). Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats. Carcinogenesis 17:1451-1457.
68. Nagel SC, vom Saal FS, and Welshons WV (1998). The effective free fraction of estradiol and xenoestrogens in human serum measured by whole cell uptake assays: Physiology of delivery modifies estrogenic activity. Proc Soc Exp Biol Med 217:300-309.
69. Nequin LG, Alvarez J, and Schwartz NB (1979). Measurement of serum steroid and gonadotropin levels and uterine and ovarian variables throughout 4 day and 5 day estrous cycles in the rat. Biol Reprod 20:659-670.
70. Pike AC, Brzozowski AM, Hubbard RE, Bonn T, Thorsell AG, Engstrom O, Ljunggren J, Gustafsson JA, and Carlquist M (1999). Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist. EMBO J 18:4608-4618.
71. Pollard M and Luckert PH (1997). Influence of isoflavones in soy protein isolates on development of induced prostate-related cancers in L-W rats. Nutr Cancer 28:41-45.
72. Ruiz-Larrea MB, Mohan AR, Paganga G, Miller NJ, Bolwell GP, and Rice-Evans CA (1997). Antioxidant activity of phytoestrogenic isoflavones. Free Radic Res 26:63-70.
73. Sadowska-Krowicka H, Mannick EE, Oliver PD, Sandoval M, Zhang XJ, Eloby-Childess S, Clark DA, and Miller MJ (1998). Genistein and gut inflammation: Role of nitric oxide. Proc Soc Exp Biol Med 217:351-357.
74. Salzman A, Preiser J-C, Setchell KDR, and Szabo C (1999). Isoflavone-mediated inhibition of tyrosine kinase: A novel anti-inflammatory approach. J Medicinal Food 2:179-181.
75. Setchell KDR (1998). Phytoestrogens: The biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr 68:1333S-1346S.
76. Setchell KDR and Adlercreutz H (1988). Mammalian lignans and phytoestrogens. Recent studies on their formation, metabolism and biological role in health and disease. In: Rowland IR, editor. Role of the gut flora in toxicity and cancer. London: Academic Press, 315-334.
77. Setchell KDR, Borriello SP, Hulme P, Kirk DN, and Axelson M (1984). Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease. Am J Clin Nutr 40:569-578.
78. Setchell KDR and Cassidy A (1999). Dietary isoflavones: Biological effects and relevance to human health. J Nutr 129:758S-767S.
79. Setchell KDR, Gosselin SJ, Welsh MB, Johnston JO, Balistreri WF, Kramer LW, Dresser BL, and Tarr MJ (1987a). Dietary estrogens: A probable cause of infertility and liver disease in captive cheetahs. Gastroenterology 93:225-233.
80. Setchell KDR, Welsh M, and Lim C (1987b). HPLC analysis of phytoestrogens in soy protein preparations with ultraviolet, electrochemical, and thermospray mass spectrometric detection. J Chromatogr 385:267-274.
81. Setchell KDR, Zimmer-Nechemias L, Cai J, and Heubi JE (1997). Exposure of infants to phyto-oestrogens from soy-based infant formula (see comments). Lancet 350:23-27.
82. Setchell KDR, Zimmer-Nechemias L, Cai J, and Heubi JE (1998). Isoflavone content of infant formulas and the metabolic fate of these phytoestrogens in early life. Am J Clin Nutr 68:1453S-1461S.
83. Sharma OP, Adlercreutz H, Strandberg JD, Zirkin BR, Coffey DS, and Ewing LL (1992). Soy of dietary source plays a preventive role against the pathogenesis of prostatitis in rats. J Steroid Biochem Mol Biol 43:557-564.
84. Sheiber MD, Setchell KDR, Liu JH, Subbiah MTR, and Rebar RW (In press, 2001). Dietary soy supplementation reduces LDL-oxidation and bone turnover in healthy postmenopausal women. Menopause.
85. Thiagarajan DG, Bennink MR, Bourquin LD, and Kavas FA (1998). Prevention of precancerous colonic lesions in rats by soy flakes, soy flour, genistein, and calcium. Am J Clin Nutr 68:1394S-1399S.
86. Thigpen JE, Setchell KD, Ahlmark KB, Locklear J, Spahr T, Caviness GF, Goelz MF, Haseman JK, Newbold RR, and Forsythe DB (1999a). Phytoestrogen content of purified, open-and closed-formula laboratory animal diets. Lab Anim Sci 49:530-536.
87. Thigpen JE, Setchell KD, Goelz MF, and Forsythe DB (1999b). The phytoestrogen content of rodent diets (letter). Environ Health Perspect 107:A182-183.
88. Tikkanen MJ, Wahala K, Ojala S, Vihma V, and Adlercreutz H (1998). Effect of soybean phytoestrogen intake on low density lipoprotein oxidation resistance. Proc Natl Acad Sci USA 95:3106-3110.
89. Tovar-Palacio C, Potter SM, Hafermann JC, and Shay NF (1997). Intake of soy protein and soy protein extracts influences lipid metabolisn and hepatic gene expression in gerbils. J Nutr 128:839-842.
90. Walter E (1941). Genistein (an isoflavone glucoside) and its aglucone, genistin, from soybeans. J Americal Oil Chem Soc 63:3273-3276.
91. Walz E (1931). Isoflavone: A Saponin glucoside in soya. Justus Liebigs Ann Chem 489:118-155.
92. Wang HJ and Murphy PA (1994). Isoflavone content in commercial soybean foods. J Agric Food Chem 42:1666-1673.
93. Weber KS, Setchell KDR, Stocco DM, and Lephart ED (In press, 2001). Dietary soy-phytoestrogens decrease testosterone levels and prostate weight, without altering LH, prostate 5-alpha reductase or testicular StAR levels in adult male Sprague-Dawley rats. J Endocrinol.
94. Wei H, Bowen R, Cai Q, Barnes S, and Wang Y (1995). Antioxidant and antipromotional effects of the soybean isoflavone genistein. Proc Soc Exp Biol Med 208:124-130.
95. Whitten PL, Lewis C, Russell E, and Naftolin F (1995). Potential adverse effects of phytoestrogens. J Nutr 125: 771S-776S.
96. Whitten PL and Naftolin F (1992). Effects of a phytoestrogen diet on estrogen-dependent reproductive processes in immature female rats. Steroids 57:56-61.
97. Whitten PL, Russell E, and Naftolin F (1992). Effects of a normal, human-concentration, phytoestrogen diet on rat uterine growth. Steroids 57:98-106.